• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊柱手术后术后阿片类药物使用时间延长的风险因素:从州立处方监测计划中审查配药趋势。

Risk Factors for Prolonged Postoperative Opioid Use After Spine Surgery: A Review of Dispensation Trends From a State-run Prescription Monitoring Program.

机构信息

From the Department of Orthopaedic Surgery, Northwestern University, Chicago, IL.

出版信息

J Am Acad Orthop Surg. 2019 Jan 1;27(1):32-38. doi: 10.5435/JAAOS-D-17-00304.

DOI:10.5435/JAAOS-D-17-00304
PMID:30199478
Abstract

INTRODUCTION

Opioid abuse and dependence have a detrimental effect on elective orthopaedic surgeries, yet pain control is an important predictor of postoperative satisfaction. We aimed at better defining risk factors for prolonged postoperative opioid requirements and risk factors for patients requiring higher doses of opioids after spine surgery.

METHODS

The Illinois Prescription Monitoring Program was queried to analyze opioid dispensation patterns at 3 and 6 months postoperatively for adult patients who had spine surgery at a tertiary care hospital by a single surgeon over a 5-year period. Patients were divided into three groups: group 1 patients had opioid dispensed to them 3 and 6 months preoperatively, group 2 patients had opioid dispensed to them only at 3 months preoperatively, and group 3 patients did not have preoperative opioid prescriptions. Demographic characteristics, psychiatric history, smoking status, alcohol use, body mass index, surgical region, and presence of multiple prescribers were abstracted. Statistical analysis included multivariate modified Poisson regression, linear regression, and chi-squared testing when appropriate.

RESULTS

Patients in group 1 were at significantly increased risk of continued opioid usage than those in group 2 (relative risk, 3.934; 95% confidence interval, 1.691 to 9.150; P = 0.0015) and those in group 3 (relative risk, 4.004; 95% confidence interval, 1.712 to 9.365; P = 0.0014) at 6 months postoperatively. Group 1 patients also had larger quantities of opioid dispensed to them relative to patients in group 2 or group 3 (P < 0.0001) at 6 months postoperatively.

DISCUSSION

Use of opioid medications at 6 months preoperatively is a risk factor for continued usage and at higher doses 6 months postoperatively.

LEVEL OF EVIDENCE

Level III: retrospective cohort study.

摘要

简介

阿片类药物滥用和依赖对择期矫形外科手术有不利影响,但疼痛控制是术后满意度的重要预测因素。我们旨在更好地定义术后阿片类药物需求延长的危险因素,以及脊柱手术后需要更高剂量阿片类药物的患者的危险因素。

方法

通过对一名外科医生在 5 年内对一家三级护理医院进行脊柱手术的成年患者的术后 3 个月和 6 个月的阿片类药物配药模式进行分析,查询伊利诺伊州处方监测计划。患者分为三组:组 1 患者在术前 3 个月和 6 个月有阿片类药物配药,组 2 患者仅在术前 3 个月有阿片类药物配药,组 3 患者没有术前阿片类药物处方。提取人口统计学特征、精神病史、吸烟状况、饮酒状况、体重指数、手术部位和多个处方医生的存在情况。适当的时候进行了多变量修正泊松回归、线性回归和卡方检验。

结果

与组 2(相对风险,3.934;95%置信区间,1.691 至 9.150;P = 0.0015)和组 3(相对风险,4.004;95%置信区间,1.712 至 9.365;P = 0.0014)相比,组 1 患者在术后 6 个月时继续使用阿片类药物的风险显著增加。与组 2 或组 3 相比,组 1 患者在术后 6 个月时也开具了更多的阿片类药物(P < 0.0001)。

讨论

术前 6 个月使用阿片类药物是术后 6 个月继续使用和更高剂量的危险因素。

证据水平

三级:回顾性队列研究。

相似文献

1
Risk Factors for Prolonged Postoperative Opioid Use After Spine Surgery: A Review of Dispensation Trends From a State-run Prescription Monitoring Program.脊柱手术后术后阿片类药物使用时间延长的风险因素:从州立处方监测计划中审查配药趋势。
J Am Acad Orthop Surg. 2019 Jan 1;27(1):32-38. doi: 10.5435/JAAOS-D-17-00304.
2
Understanding Opioid Use After Total Hip Arthroplasty: A Comprehensive Analysis of a Mandatory Prescription Drug Monitoring Program.理解全髋关节置换术后阿片类药物的使用:对强制性处方药物监测计划的综合分析。
J Am Acad Orthop Surg. 2020 Oct 15;28(20):e917-e922. doi: 10.5435/JAAOS-D-19-00676.
3
Preoperative Opioid Prescription Filling Is a Risk Factor for Prolonged Opioid Use After Elbow Arthroscopy.术前阿片类药物处方的开具是肘关节镜检查后阿片类药物使用时间延长的危险因素。
Arthroscopy. 2020 Aug;36(8):2106-2113. doi: 10.1016/j.arthro.2020.04.053. Epub 2020 May 20.
4
Incidence and Risk Factors for Chronic Postoperative Opioid Use After Major Spine Surgery: A Cross-Sectional Study With Longitudinal Outcome.术后慢性阿片类药物使用的发生率和风险因素:一项具有纵向结局的大脊柱手术后的横断面研究。
Anesth Analg. 2018 Jul;127(1):247-254. doi: 10.1213/ANE.0000000000003338.
5
Development of a clinical risk calculator for prolonged opioid use after shoulder surgery.开发一种用于肩手术后延长阿片类药物使用的临床风险计算器。
J Shoulder Elbow Surg. 2019 Nov;28(11):2225-2231. doi: 10.1016/j.jse.2019.03.033. Epub 2019 Jul 3.
6
Effect of narcotic prescription limiting legislation on opioid utilization following lumbar spine surgery.限制麻醉性处方立法对腰椎手术后阿片类药物使用的影响。
Spine J. 2019 Apr;19(4):717-725. doi: 10.1016/j.spinee.2018.09.007. Epub 2018 Sep 14.
7
Who Is Prescribing Opioids Preoperatively? A Survey of New Patients Presenting to Tertiary Care Adult Reconstruction Clinics.谁在术前开阿片类药物?对三级护理成人重建诊所新就诊患者的调查。
J Am Acad Orthop Surg. 2020 Apr 1;28(7):301-307. doi: 10.5435/JAAOS-D-19-00602.
8
Preoperative Risk Factors for Opioid Utilization After Total Hip Arthroplasty.全髋关节置换术后阿片类药物使用的术前危险因素。
J Bone Joint Surg Am. 2019 Sep 18;101(18):1670-1678. doi: 10.2106/JBJS.18.01005.
9
Comparing different chronic preoperative opioid use definitions on outcomes after spine surgery.比较脊柱手术后不同慢性术前阿片类药物使用定义的结果。
Spine J. 2019 Jun;19(6):984-994. doi: 10.1016/j.spinee.2018.12.014. Epub 2019 Jan 8.
10
Validating the Stopping Opioids after Surgery (SOS) score for sustained postoperative prescription opioid use in spine surgical patients.验证术后停止使用阿片类药物(SOS)评分在脊柱手术患者中持续术后处方阿片类药物使用的适用性。
Spine J. 2019 Oct;19(10):1666-1671. doi: 10.1016/j.spinee.2019.05.001. Epub 2019 May 9.

引用本文的文献

1
The Effects of Opioid Dependency Use on Postoperative Spinal Surgery Outcomes: A Review of the Available Literature.阿片类药物依赖使用对脊柱手术后结果的影响:现有文献综述
Anesth Pain Med. 2023 Jul 4;13(4):e136563. doi: 10.5812/aapm-136563. eCollection 2023 Aug.
2
Association of inpatient opioid consumption on postoperative outcomes after open posterior spinal fusion for adult spine deformity.成人脊柱畸形后路切开融合术后住院期间阿片类药物消耗量与术后结局的相关性
Spine Deform. 2023 Mar;11(2):439-453. doi: 10.1007/s43390-022-00609-2. Epub 2022 Nov 9.
3
Opioid Use Patterns in a Statewide Adult Medicaid Population Undergoing Elective Lumbar Spine Surgery.
全州成年医疗补助计划接受择期腰椎手术患者的阿片类药物使用模式。
Spine (Phila Pa 1976). 2023 Feb 1;48(3):203-212. doi: 10.1097/BRS.0000000000004503. Epub 2022 Oct 4.
4
Preoperative opiate use leads to increased postoperative opiate use and readmissions after anterior cervical discectomy and fusion.术前使用阿片类药物会导致颈椎前路椎间盘切除融合术后阿片类药物使用量增加及再入院率升高。
J Spine Surg. 2022 Jun;8(2):214-223. doi: 10.21037/jss-21-126.
5
The Drivers of Persistent Opioid Use and Its Impact on Healthcare Utilization After Elective Spine Surgery.择期脊柱手术后持续使用阿片类药物的驱动因素及其对医疗保健利用的影响。
Global Spine J. 2024 Mar;14(2):370-379. doi: 10.1177/21925682221104731. Epub 2022 May 23.
6
Opioid use prior to surgery is associated with worse preoperative and postoperative patient reported quality of life and decreased surgical cost effectiveness for symptomatic adult spine deformity; A matched cohort analysis.术前使用阿片类药物与有症状的成人脊柱畸形患者术前和术后报告的生活质量较差以及手术成本效益降低相关;一项匹配队列分析。
N Am Spine Soc J. 2021 Dec 12;9:100096. doi: 10.1016/j.xnsj.2021.100096. eCollection 2022 Mar.
7
An Update on Postoperative Opioid Use and Alternative Pain Control Following Spine Surgery.脊柱手术后阿片类药物使用及替代疼痛控制的最新进展
Orthop Rev (Pavia). 2021 Jun 22;13(2):24978. doi: 10.52965/001c.24978. eCollection 2021.
8
Predictors of Prolonged Opioid Use After Lumbar Fusion and the Effects of Opioid Use on Patient-Reported Outcome Measures.腰椎融合术后长期使用阿片类药物的预测因素以及阿片类药物使用对患者报告结局指标的影响。
Global Spine J. 2021 Sep 6;13(6):21925682211041968. doi: 10.1177/21925682211041968.
9
The impact of preoperative motor weakness on postoperative opioid use after ACDF.前路颈椎间盘切除融合术(ACDF)术前运动功能减弱对术后阿片类药物使用的影响。
J Orthop. 2021 Jun 30;26:23-28. doi: 10.1016/j.jor.2021.06.003. eCollection 2021 Jul-Aug.
10
Preoperative Maximization to Reduce Complications in Spinal Surgery.脊柱手术术前优化以减少并发症
Global Spine J. 2020 Jan;10(1 Suppl):45S-52S. doi: 10.1177/2192568219882349. Epub 2020 Jan 6.